Sort
21,281 grants matching “influenza”
CAREER: Integrating Chemical Biology Methods and RNA Virus Models to Elucidate How the Metazoan Proteostasis Network Modulates Protein Evolutionary Landscapes
$1,034,621Matthew D Shoulders · Massachusetts Institute Of Technology · · FY2017 · BIO
Supporting RADx Technology Development: Leveraging International Networks and Clinical Context
$1,032,628Yukari C Manabe · Johns Hopkins University · U54 · FY2022 · EB
Viral Vector Core
$1,032,048Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2020 · ES
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$1,030,988Kathy L Rowlen · Indevr, Inc. · R44 · FY2015 · AI
Core 3: Biocontainment Research Support Services Core
$1,029,538Colin S. Duckett · Duke University · UC7 · FY2023 · AI
Comparative Biomedical Scientist Training Program
$1,029,500Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2016 · CA
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform
$1,028,842Lyndsey Linke · Sivec Biotechnologies, Llc · R44 · FY2020 · AI
Experimental characterization of the dynamics of immune responses to influenza
$1,028,598Rafi Ahmed · Emory University · U19 · FY2016 · AI
Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza
$1,027,798Aaron Esser-Kahn · University Of Chicago · N01 · FY2024 · AI
Protein-mediated membrane remodeling
$1,027,723Leonid V. Chernomordik · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$1,027,331Gail Geller · Johns Hopkins University · RM1 · FY2017 · HG
A dual vaccine strategy against filovirus infection
$1,027,065Richard W Compans · Emory University · R01 · FY2014 · AI
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
$1,027,000Victor Nizet · University Of California, San Diego · R01 · FY2023 · AI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
$1,026,895Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2011 · AI
A Handheld Microchip for GC analysis of breath to screen for COVID-19
$1,026,672Xiao-An Fu · University Of Louisville · U18 · FY2021 · TR
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
$1,026,596Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$1,026,345Ann R Falsey · University Of Rochester · UM1 · FY2023 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$1,025,901Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2019 · AI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
$1,025,685Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2014 · AI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
$1,025,685Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2012 · AI
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,025,389Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2013 · AI
Point-of-care Diagnosis and Surveillance of Known and Emerging Influenza Viruses
$1,025,262Timothy M Rose · Seattle Children'S Hospital · R01 · FY2017 · AI
ADJUVANT COMPARISON AND CHARACTERIZATION
$1,025,064Philip Felgner · University Of California-Irvine · N01 · FY2024 · AI
Wastewater data integration and modelling to accurately predict viral outbreaks in long-term care facilities
$1,025,000Aaron Addison Best · Aquora Research And Consulting Llc · R44 · FY2025 · AI
Wastewater data integration and modelling to accurately predict viral outbreaks in long-term care facilities
$1,025,000Aaron Addison Best · Aquora Research And Consulting Llc · R44 · FY2024 · AI